The Substance continues to be researched inside the patent literature for its anxiolytic Homes and decreased sedative, hypnotic, and ataxic side-effects, but it doesn't appear to be licensed for healthcare use. Łukasik-Głebocka et al Flubromazolam was first identified in a sample of 10 white rectangle shaped tablets labelled “XANAX”, seized https://chemicalglobe.com/